Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

USE OR METABOLOMIC MARKERS OF RESPONSE TO FISH OIL SUPPLEMENTATION TO IDENTIFY EF

Award Number: R21AT006082
ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/29/2010
PERIOD OF PERFORMANCE END DATE: 08/31/2013

Group Awards By:

View Award Description

USE OR METABOLOMIC MARKERS OF RESPONSE TO FISH OIL SUPPLEMENTATION TO IDENTIFY EF - DESCRIPTION (provided by applicant): We recently completed an NCCAM-funded R21 clinical trial entitled "Variation in the ALOX5 gene and response to omega-3 fatty acid supplements" (R21 AT003411, C. Stephensen, PI; ClinicalTrials.gov Identifier, NCT00536185). A total of 116 subjects of African ancestry were randomized within ALOX5 promoter genotypes to 5 g/day fish oil concentrate or 5 g/day corn/soy placebo oil for a six week intervention; 98 subjects completed the trial. In brief, there was a significant, beneficial effect of fish oil supplementation on plasma lipid and lipoprotein profiles and on markers of inflammation. However, there was a wide range of responses for these variables. We hypothesize that accounting for variability in subject responses to fish oil intervention will increase our ability to see significant differences in markers of inflammation linked to development of chronic inflammatory diseases. In the present proposal we plan to use two markers of response to supplementation to quantify this variability. The first marker is the change in fatty acid composition of erythrocyte cell membranes in response to supplementation, focusing on arachadonic acid (AA) and the two principal omega-3 fatty acids from fish oil, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These data are available from the parent study. The second marker set will be developed from plasma concentrations of a panel of 18- to 20-carbon omega-3 and omega-6 fatty acid metabolites that will be measured along with an array of leukotrienes (LT), prostaglandins (PG) and thromboxanes (TX) for the study proposed here. We will determine if these erythrocyte or plasma biomarkers of omega-3 intake will predict changes in markers of inflammation by specific, highly purified cell types (monocyte, granulocyte, lymphocyte) more reliably than using the fish oil/placebo designation. Monocyte data are available from the parent study while granulocyte and lymphocyte samples saved from the parent study will be analyzed for this proposal. We will also determine if these biomarkers will predict changes in plasma markers of systemic inflammation, including plasma concentrations of LT, PG and TX measured for this study, and concentrations of 46 plasma protein markers of inflammation to be measured for this study, including cytokines, chemokines, soluble cell adhesion molecules, acute phase proteins, proteases and anti-proteases, and complement components. PUBLIC HEALTH RELEVANCE: Chronic inflammatory diseases are a major health concern for the US population. Dietary and other complementary and alternative medicine interventions can decrease the severity of such inflammation and thus improve health. Evaluating the impact of such interventions on inflammation is difficult because of the variability of response by individuals resulting from behavioral, environmental and genetic differences. In this study we will develop and evaluate biomarkers of response to intake of fish oil supplements that will improve our ability to evaluate the impact of such interventions on inflammation and risk of chronic inflammatory disease.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2013 ( Subtotal = $0 )
2013	2011	US DEPARTMENT OF AGRICULTURE, SOIL CONSERVATION SERVICE	4601 LOCUST LANE	HARRISBURG	PA	17109	DAUPHIN	USA	Research and Training in Complementary and Integrative Health	000	2	12/17/2012	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2011 ( Subtotal = $74,250 )
2011	2011	US DEPARTMENT OF AGRICULTURE, SOIL CONSERVATION SERVICE	4601 LOCUST LANE	HARRISBURG	PA	17109	DAUPHIN	USA	Research and Training in Complementary and Integrative Health	000	2	8/26/2011	NON-COMPETING CONTINUATION	$74,250
														Subtotal = $74,250

Issue Date FY: 2010 ( Subtotal = $200,000 )
2010	2010	US DEPARTMENT OF AGRICULTURE, SOIL CONSERVATION SERVICE	4601 LOCUST LANE	HARRISBURG	PA	17109	DAUPHIN	USA	Research and Training in Complementary and Integrative Health	000	1	9/22/2010	NEW	$200,000
														Subtotal = $200,000

Grand Total All Awards = $274,250

Top

All Categories

About

Search

Reports

Data Submission

Award Information

USE OR METABOLOMIC MARKERS OF RESPONSE TO FISH OIL SUPPLEMENTATION TO IDENTIFY EF

Award Number: R21AT006082

ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/29/2010

PERIOD OF PERFORMANCE END DATE: 08/31/2013

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer